| 1 |
Dopamine D2 receptor signaling modulates pancreatic beta cell circadian rhythms |
|
|
| Heather Wei,Rizaldy C. Zapata,Mariela Lopez-Valencia,Despoina Aslanoglou,Zachary J. Farino,Valerie Benner,Olivia Osborn,Zachary Freyberg,Michael J. McCarthy |
|
| Psychoneuroendocrinology. 2020; 113: 104551 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Circadian-timed quick-release bromocriptine lowers elevated resting heart rate in patients with type 2 diabetes mellitus |
|
|
| Bindu Chamarthi,Aaron Vinik,Michael Ezrokhi,Anthony H. Cincotta |
|
| Endocrinology, Diabetes & Metabolism. 2019; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain |
|
|
| Diana Grajales,Vitor Ferreira,Ángela M. Valverde |
|
| Cells. 2019; 8(11): 1336 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Novel Trajectories of Bromocriptine Antidiabetic Action: Leptin-IL-6/ JAK2/p-STAT3/SOCS3, p-IR/p-AKT/GLUT4, PPAR-?/Adiponectin, Nrf2/PARP-1, and GLP-1 |
|
|
| Enji Reda,Sherifa Hassaneen,Hanan S. El-Abhar |
|
| Frontiers in Pharmacology. 2018; 9 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances |
|
|
| Zachary Freyberg,Michael J. McCarthy |
|
| npj Schizophrenia. 2017; 3(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Bromocriptine treatment at the end of lactation prevents hyperphagia, higher visceral fat and liver triglycerides in early-weaned rats at adulthood |
|
|
| Nayara Peixoto-Silva,Egberto G Moura,Janaine C Carvalho,Jéssica L Nobre,Fernanda T Quitete,Cintia R Pinheiro,Ana Paula Santos-Silva,Elaine de Oliveira,Patricia C Lisboa |
|
| Clinical and Experimental Pharmacology and Physiology. 2017; 44(4): 488 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases |
|
|
| Alexander O Shpakov,Kira V Derkach,Lev M Berstein |
|
| Future Science OA. 2015; 1(3) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Effect of Bromocriptine on Insulin Resistance in Patients with PCO |
|
|
| Zivar Shirinpour,Bahman Ghaderian,Homeira Rashidi,Armaghan Moravej Aleali,Seyed Peyman Payami |
|
| Open Journal of Endocrine and Metabolic Diseases. 2014; 04(12): 253 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Bromocriptine mesylate QR in treatment of Type 2 diabetes |
|
|
| George Grunberger |
|
| Diabetes Management. 2014; 4(2): 203 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
New therapies in the management of type 2 diabetes mellitus |
|
|
| TC Hardman,SW Dubrey |
|
| British Journal of Hospital Medicine. 2013; 74(4): 202 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 11 |
Overview of food products and dietary constituents with antidiabetic properties and their putative mechanisms of action: A natural approach to complement pharmacotherapy in the management of diabetes |
|
|
| Isabelle M. E. Lacroix,Eunice C. Y. Li-Chan |
|
| Molecular Nutrition & Food Research. 2013; : n/a |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 12 |
An atlas and functional analysis of G-protein coupled receptors in human islets of Langerhans |
|
|
| Stefan Amisten,Albert Salehi,Patrik Rorsman,Peter M. Jones,Shanta J. Persaud |
|
| Pharmacology & Therapeutics. 2013; 139(3): 359 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
